BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.01B |
| 3 |
Amazon
AMZN
|
+$960M |
| 4 |
Alibaba
BABA
|
+$859M |
| 5 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$642M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$702M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$682M |
| 3 |
CME Group
CME
|
+$627M |
| 4 |
Nektar Therapeutics
NKTR
|
+$598M |
| 5 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$585M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.05% |
| 2 | Financials | 15.61% |
| 3 | Healthcare | 12.97% |
| 4 | Industrials | 10.15% |
| 5 | Consumer Discretionary | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
2001
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $78.6M | ﹤0.01% |
1,277,197
+83,235
| +7% | +$5.02M |
|
2002
DXP Enterprises
DXPE
$2.53B
| $78.5M | ﹤0.01% |
2,014,560
+20,156
| +1% | +$661K |
|
|
VEDL
2003
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $78M | ﹤0.01% |
4,438,996
+183,719
| +4% | +$3.7M |
|
|
ENIA
2004
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $78M | ﹤0.01% |
6,710,977
+292,473
| +5% | +$3.35M |
|
|
TIER
2005
DELISTED
TIER REIT, Inc.
TIER
| $77.9M | ﹤0.01% |
4,216,901
-2,873
| -0.1% | -$54.6K |
|
|
HAPN
2006
Happen Inc
HAPN
$2.36B
| $77.9M | ﹤0.01% |
4,451,596
+34,695
| +0.8% | +$668K |
|
|
HES.PRA
2007
DELISTED
Hess Corporation
HES.PRA
| $77.8M | ﹤0.01% |
+1,306,669
| New | +$76.4M |
|
|
IPHI
2008
DELISTED
INPHI CORPORATION
IPHI
| $77.8M | ﹤0.01% |
2,585,329
-142,443
| -5% | -$4.43M |
|
|
SUPV
2009
Grupo Supervielle
SUPV
$828M
| $77.2M | ﹤0.01% |
2,543,134
-549,843
| -18% | -$16.9M |
|
2010
UNIFI
UFI
$119M
| $76.9M | ﹤0.01% |
2,121,133
+26,960
| +1% | +$965K |
|
|
WAIR
2011
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $76.8M | ﹤0.01% |
7,496,378
-168,734
| -2% | -$1.43M |
|
2012
Floor & Decor
FND
$6.08B
| $76.8M | ﹤0.01% |
1,473,155
-193,923
| -12% | -$9.16M |
|
|
HSII
2013
DELISTED
Heidrick & Struggles
HSII
| $76.8M | ﹤0.01% |
2,456,773
+42,250
| +2% | +$1.15M |
|
|
DVAX
2014
DELISTED
Dynavax Technologies
DVAX
| $76.7M | ﹤0.01% |
3,864,788
-9,095
| -0.2% | -$157K |
|
|
RBS.PRS.CL
2015
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
| $76.6M | ﹤0.01% |
2,992,916
+97,444
| +3% | +$2.5M |
|
|
VIVO
2016
DELISTED
Meridian Bioscience Inc
VIVO
| $76.4M | ﹤0.01% |
5,382,301
+109,220
| +2% | +$1.62M |
|
|
XENT
2017
DELISTED
Intersect ENT, Inc
XENT
| $76.2M | ﹤0.01% |
1,938,279
-42,663
| -2% | -$1.56M |
|
2018
TriMas Corp
TRS
$1.43B
| $76M | ﹤0.01% |
2,894,677
-12,998
| -0.4% | -$337K |
|
|
TWNK
2019
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $75.8M | ﹤0.01% |
5,124,907
-18,960
| -0.4% | -$265K |
|
2020
First Busey Corp
BUSE
$2.6B
| $75.6M | ﹤0.01% |
2,544,774
+14,792
| +0.6% | +$455K |
|
2021
ANI Pharmaceuticals
ANIP
$1.82B
| $75.5M | ﹤0.01% |
1,296,388
+22,037
| +2% | +$1.4M |
|
2022
Donnelley Financial Solutions
DFIN
$1.2B
| $75.4M | ﹤0.01% |
4,388,824
+129,104
| +3% | +$2.52M |
|
|
SVU
2023
DELISTED
SUPERVALU Inc.
SVU
| $75.3M | ﹤0.01% |
4,945,077
+71,988
| +1% | +$1.14M |
|
2024
American Vanguard Corp
AVD
$70.4M
| $75.2M | ﹤0.01% |
3,725,111
+68,530
| +2% | +$1.42M |
|
2025
Axogen
AXGN
$2.46B
| $75.2M | ﹤0.01% |
2,060,044
+274,153
| +15% | +$8.41M |
|
Similar funds
BlackRock's Q1 2018 Portfolio in Review
As of Q1 2018, BlackRock held 5,137 positions worth $2.09T, down 0.47% from $2.1T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock's Q1 2018 filing shows 155 new, 2,323 increased, 1,970 reduced and 164 closed positions. Its largest new stake was Dropbox: 10,477,103 shares worth $327M. The largest sale was Lockheed Martin, an estimated $702M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q1 2018 buy was Dropbox: 10,477,103 shares worth $327M.
- BlackRock added most to Johnson & Johnson in Q1 2018, an estimated $1.06B increase.
- BlackRock's biggest Q1 2018 reduction was Lockheed Martin, cutting an estimated $702M.
- BlackRock fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $585M.
- BlackRock's ten largest holdings make up 14% of its $2.09T portfolio in Q1 2018.
- BlackRock opened 155 new positions and closed 164 in Q1 2018.
- BlackRock's portfolio value fell 0.47% quarter-over-quarter to $2.09T.
Based on BlackRock's 13F filing for Q1 2018, filed 9 May 2018.